Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 140 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
|
Company Propella Therapeutics Inc. | Activity: Research and Development | Company Description Propella Therapeutics has developed a platform which combines lymphatic targeting with a medicinal chemistry optimization process to create therapeutics for cancer. The lead asset is PRL-02 (abiraterone decanoate) for prostate cancer. | Location Pittsboro |
 |
Company Acclivity Technologies Inc. | Activity: Research and Development | Company Description Acclivity is a virtual pharma company developing novel small molecule therapeutics for treatment of peripheral artery disease and other cardiovascular, inflammatory and ischemic disease indications, vasculitis and type 2 diabetes. | Location Raleigh |
| |
Company AccuNovo Biotechnologies Inc. | Activity: Research and Development | Company Description Accunovo is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. | Location Chapel Hill |
| |
Company Achelios Therapeutics Inc. | Activity: Research and Development | Company Description Achelios Therapeutics develops novel topical therapies for inflammatory pain, such as joint, muscle temporomandibular and migraine pain. | Location Durham |
| |
Company Adroit Pharmaceutical Development LLC | Activity: Contract Research and Testing | Company Description Adroit Pharmaceutical Development identifies new and improved formulations and process technologies. Its primary focus is on inhalation and dermatological product development. | Location Durham |
| |
Company AegisCN LLC | Activity: Research and Development | Company Description AegisCN develops technologies and treatments targeting neurological diseases and inflammation. | Location Durham |
| |
Company Aer Therapeutics | Activity: Research and Development | Company Description Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung diseases with excess mucus and mucus plugs. | Location Raleigh |
| |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer’s disease when clinical signs are not yet pronounced. | Location Durham |
| |
Company AimMax Therapeutics Inc. | Activity: Research and Development | Company Description AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners. | Location Durham |
| |
Company Aktis Oncology | Activity: Research and Development | Company Description Aktis Oncology is developing targeted radiopharmaceuticals to treat solid tumor cancers. | Location Durham |
| |
Company Amalgent Therapeutics Inc. | Activity: Research and Development | Company Description Amalgent is a clinical-stage company developing novel pain management therapeutics for the treatment of pain without addiction. | Location Greenville |
| |
Company AMO Pharma Ltd. | Activity: Research and Development | Company Description AMO Pharma is developing new treatments for serious and debilitating diseases including rare genetic disorders. | Location Durham |
| |
Company Aniluxx Biotechnology Inc. | Activity: Research and Development | Company Description Aniluxx Biotechnology translates human therapies to dogs, cats and horses to treat itching and pain. | Location Chapel Hill |
| |
Company AntiXero LLC | Activity: Research and Development | Company Description AntiXero is developing a therapy for cancer-related dry mouth. | Location Raleigh |
| |
Company APIE Therapeutics Inc. | Activity: Research and Development | Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. | Location Research Triangle Park |
| |
Company Archerfish Co. | Activity: Research and Development | Company Description Archerfish develops small molecule drugs to reduce tissue fibrosis and corneal scarring. | Location Cary |
| |
Company Ardeal Pharma Inc. | Activity: Research and Development | Company Description Ardeal Pharma is a virtual pharma company developing patented stabilized sulforaphane for the dermal pharmaceutical and cosmetic markets. | Location Brevard |
| |
Company Ardeal Research Institute | Activity: Research and Development | Company Description Ardeal Research Institute is a non-profit organization that develops drug discovery capabilities of the natural resources in Western North Carolina. The Institute has collaboration agreements in place with Brevard College and the N.C. Arboretum. | Location Brevard |
| |
Company Areteia Therapeutics Inc. | Activity: Research and Development | Company Description Areteia Therapeutics is developing the first oral drug for eosinophilic asthma. | Location Chapel Hill |
| |
Company Arrivo BioVentures LLC | Activity: Research and Development | Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. | Location Morrisville |
| |
Company Auration Biotech Inc. | Activity: Research and Development | Company Description Auration Biotech is developing novel therapeutics for ear, nose and throat diseases. | Location Chapel Hill |
| |
Company Avior Inc. | Activity: Research and Development | Company Description Avior is a clinical-stage pharmaceutical company developing treatments for patients suffering from chronic liver disease (CLD) associated pruritus and pruritus in atopic dermatitis. | Location Cary |
| |
Company Balanced Pharma Inc. | Activity: Research and Development | Company Description Balanced Pharma is developing pH-balanced (buffered) injectable anesthetic drugs with enhanced usability qualities for use in dental and dermatological surgery. | Location Cornelius |
| |
Company Ballek Biologics LLC | Activity: Research and Development | Company Description Ballek Biologics is developing a therapeutic to reverse opioid overdose. | Location Raleigh |
| |
Company Banner Life Sciences LLC | Activity: Research and Development | Company Description Banner Life Sciences develops formulation technologies (gelcaps, tablets and sterile injectables) and licenses and markets prescription, over-the-counter and nutritional products. | Location High Point |
| |
Company Bantam Pharmaceutical LLC | Activity: Research and Development | Company Description Bantam Pharmaceutical develops small molecule cancer therapeutics for hematological malignancies and select solid tumors. | Location Durham |
| |
Company Base4 Biotechnology Inc. | Activity: Research and Development | Company Description Base4 is developing a biotechnology platform designed to visualize RNA dynamics at the atomic level. The company's platform aids in small molecule drug discovery. | Location Durham |
| |
Company Belhaven Biopharma Inc. | Activity: Research and Development | Company Description Belhaven Biopharma is developing dry powder nasal products for a variety of indications. | Location Raleigh |
| |
Company BioKier Inc. | Activity: Research and Development | Company Description BioKier develops proprietary adjuvant treatments for diabetes and related disorders. BioKier has identified a therapeutic opportunity based on gastric bypass surgery and is developing several novel treatments for cardiometabolic diseases including hyperlipidemia and insulin resistance. | Location Chapel Hill |
| |
Company BioLink Life Sciences Inc. | Activity: Contract Research and Testing | Company Description BioLink provides contract product development support through custom synthesis and testing for the pharmaceutical, nutraceuticals, animal health and chemical industries. | Location Cary |
| |
Company Bionpharma Inc. | Activity: Sales and Operations | Company Description Bionpharma partners with pharmaceutical companies to in-license, out-license, develop, manufacture and distribute generic and over-the-counter products. Its Raleigh location is a sales office. | Location Morrisville |
| |
Company Blue Ridge Institute for Medical Research | Activity: Research and Development | Company Description Blue Ridge Institute for Medical Research (BRIMR) researches small-molecule inhibitors of protein kinases and targeted cancer therapies. BRIMR also generates an annual ranking of NIH funding for U.S. medical schools and their departments. | Location Hendersonville |
| |
Company Bryn Pharma LLC | Activity: Research and Development | Company Description Bryn Pharma is developing a nasal solution for the administration of emergency epinephrine for the treatment of anaphylaxis. | Location Raleigh |
| |
Company Campbell University Pharmaceutical Education and Research Center (PERC) | Activity: Contract Research and Testing | Company Description The Pharmaceutical Education & Research Center (PERC) offers analytical, formulation, R&D, clinical manufacturing and training services to the pharma and biotech industries, compounding pharmacies, government agencies and other academic institutions. | Location Buies Creek |
| |
Company Cancer Advances Inc. | Activity: Research and Development | Company Description Cancer Advances, a subsidiary of Cato Bioventures, develops immunomodulator therapeutics to treat gastrointestinal cancers. | Location Durham |
| |
Company CardioPharma Inc. | Activity: Research and Development | Company Description CardioPharma develops combinatorial products to treat cardiovascular disease. | Location Wilmington |
| |
Company Cloud Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases. | Location Research Triangle Park |
| |
Company CogniKey Pharma LLC | Activity: Contract Research and Testing | Company Description CogniKey Pharma develops drugs to treat cognitive impairment in CNS disorders. CogniKey has a special interest in the treatment of Mild Cognitive Impairment (MCI). | Location Winston-Salem |
| |
Company Cognosci Inc. | Activity: Research and Development | Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. | Location Durham |
| |
Company Collaborations Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Collaborations Pharmaceuticals develops drugs for rare and neglected diseases using machine learning software, providing preclinical and clinical expertise to rare disease foundations, academic scientists and companies developing clinical candidates. Collaborations also provides machine learning expertise and software to consumer product and agrochemical companies. | Location Raleigh |
| |
Company Countervail Corp. | Activity: Research and Development | Company Description Countervail is developing proprietary drug and diagnostic technologies to detect exposure to and prevent adverse effects from organophosphate pesticides. | Location Mint Hill |
| |
Company Dechra Pharmaceuticals | Activity: Research and Development | Company Description Dechra Pharmaceuticals develops veterinary pharmaceuticals with a focus on major companion animal categories. | Location Greensboro |
| |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill |
| |
Company Dignify Therapeutics LLC | Activity: Research and Development | Company Description Dignify Therapeutics develops novel bowel and bladder therapies for people with neurological disorders and the elderly that suffer from incontinence. | Location Research Triangle Park |
| |
Company Drive Therapeutics LLC | Activity: Research and Development | Company Description Drive Therapeutics is developing therapeutics for wet age-related macular degeneration (wAMD) and diabetic retinopathy/diabetic macular edema (DR/DME). | Location Research Triangle Park |
| |
Company Eclipse Life Sciences Inc. | Activity: Research and Development | Company Description Eclipse Life Sciences is developing therapeutic compounds to treat front-of-the-eye diseases, such as uveitis and dry eye, as well as back-of-the-eye diseases, such as wet or dry macular degeneration or diabetic retinopathy. | Location Research Triangle Park |
| |
Company Emergo Therapeutics Inc. | Activity: Research and Development | Company Description Emergo Therapeutics develops drugs to reduce the production of inflammatory cytokines from mast cells and improve the functioning of the immune system in various potential indications, starting with infectious diseases. | Location Durham |
| |
Company Endacea Inc. | Activity: Research and Development | Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. | Location Research Triangle Park |
| |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham |
| |
Company Eppin Pharma Inc. | Activity: Research and Development | Company Description Eppin Pharma is developing a non-hormonal male oral contraceptive. | Location Durham |